Skip to main content

Table 2 Sample TTO Utilities/Categories of Utility

From: 1842676957299765Latent class cluster analysis to understand heterogeneity in prostate cancer treatment utilities

Utility

Mean (SD) (IQR) or n (%)

40% Chance of Erectile Dysfunction**

.9156 (.146) (.857 to 1.0)

   No-trade

137 (56.4%)

   .75 to .99

82 (33.7%)

   .50 to .74

19 (7.8%)

   Up to .49

5 (2.1%)

80% Chance of Erectile Dysfunction*

.8636 (.187) (.786 to 1.0)

   No-trade

94 (38.7%)

   .75 to .99

108 (44.4%)

   .50 to .74

30 (12.3%)

   Up to .49

11 (4.5%)

10% Chance of Incontinence**

.9544 (.120) (.929 to 1.0)

   No-trade

181 (74.5%)

   .75 to .99

52 (21.4%)

   .50 to .74

7 (2.9%)

   Up to .49

3 (1.2%)

30% Chance of Incontinence*

.8831 (.186) (.857 to 1.0)

   No-trade

114 (47.7%)

   .75 to .99

92 (38.5%)

   .50 to .74

23 (9.6%)

   Up to .49

10 (4.2%)

40% Chance of Erectile Dysfunction + 10% Chance of Incontinence**

.8358 (.196) (.757 to 1.0)

   No-trade

65 (26.6%)

   .75 to .99

133 (54.5%)

   .50 to .74

32 (13.1%)

   Up to .49

14 (5.7%)

  1. TTO = time trade-off
  2. ** Risk associated with Radiation Therapy
  3. *Risk associated with Radical Prostatectomy